Sample Name
Sample Code
Sample Name
Sample Code
Sample Name
Sample Code
4
BIDU-SW
09888
5
JD HEALTH
06618
| (Q3)Sep 30, 2025 | (Q2)Jun 30, 2025 | (Q1)Mar 31, 2025 | (FY)Dec 31, 2024 | (Q4)Dec 31, 2024 | (Q3)Sep 30, 2024 | (Q2)Jun 30, 2024 | (Q1)Mar 31, 2024 | (FY)Dec 31, 2023 | (Q4)Dec 31, 2023 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Total revenue | -5.39%2.47B | -5.80%2.47B | -6.12%2.7B | 29.45%10.67B | 9.49%2.56B | 18.01%2.61B | 47.08%2.62B | 50.76%2.88B | 3.02%8.24B | 15.56%2.34B |
| Operating revenue | -5.39%2.47B | -5.80%2.47B | -6.12%2.7B | 29.45%10.67B | 9.49%2.56B | 18.01%2.61B | 47.08%2.62B | 50.76%2.88B | 3.02%8.24B | 15.56%2.34B |
| Cost of revenue | -5.48%2.36B | -5.89%2.38B | -6.09%2.59B | 32.57%10.25B | 12.82%2.46B | 19.97%2.5B | 50.03%2.53B | 55.00%2.76B | 2.97%7.73B | 14.71%2.18B |
| Gross profit | -3.48%111M | -3.23%90M | -6.90%108M | -17.58%422M | -37.18%98M | -12.88%115M | -4.12%93M | -8.66%116M | 3.85%512M | 28.93%156M |
| Operating expense | -4.88%39M | -13.89%31M | -6.52%43M | 0.64%158M | -20.45%35M | 7.89%41M | 0.00%36M | 17.95%46M | 10.56%157M | 57.14%44M |
| Selling and administrative expenses | -8.11%34M | -15.63%27M | -4.88%39M | 3.68%141M | -18.42%31M | 12.12%37M | 6.67%32M | 17.14%41M | 14.29%136M | 65.22%38M |
| -General and administrative expense | -8.11%34M | -15.63%27M | -4.88%39M | 3.68%141M | -18.42%31M | 12.12%37M | 6.67%32M | 17.14%41M | 14.29%136M | 65.22%38M |
| Depreciation amortization depletion | 0.00%2M | 0.00%2M | -33.33%2M | 0.00%9M | -33.33%2M | 0.00%2M | -33.33%2M | 200.00%3M | -30.77%9M | 0.00%3M |
| -Depreciation and amortization | 0.00%2M | 0.00%2M | -33.33%2M | 0.00%9M | -33.33%2M | 0.00%2M | -33.33%2M | 200.00%3M | -30.77%9M | 0.00%3M |
| -Depletion | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 | --0 |
| Other operating expenses | 50.00%3M | 0.00%2M | 0.00%2M | -33.33%8M | -33.33%2M | -33.33%2M | -33.33%2M | -33.33%2M | 20.00%12M | 50.00%3M |
| Operating profit | -2.70%72M | 3.51%59M | -7.14%65M | -25.63%264M | -43.75%63M | -21.28%74M | -6.56%57M | -20.45%70M | 1.14%355M | 20.43%112M |
| Net non-operating interest income (expenses) | -40.00%-14M | -54.55%-17M | 25.00%-12M | 44.05%-47M | 52.38%-10M | 54.55%-10M | 47.62%-11M | 20.00%-16M | 3.45%-84M | 4.55%-21M |
| Non-operating interest expense | 40.00%14M | 70.00%17M | -26.67%11M | -45.12%45M | -54.55%10M | -52.38%10M | -50.00%10M | -25.00%15M | -2.38%82M | 0.00%22M |
| Total other finance cost | ---- | ---- | 0.00%1M | 0.00%2M | --0 | ---- | 0.00%1M | --1M | -33.33%2M | ---1M |
| Other net income (expenses) | -56M | -100.59%-3M | 4,609.09%496M | 30.00%-7M | -175.00%-3M | 10,020.00%506M | 8.33%-11M | 37.50%-10M | ||
| Gain on sale of security | ---- | ---- | ---- | ---- | ---- | ---- | ---- | ---- | --8M | ---- |
| Special income (charges) | ---3M | 50.00%-1M | -100.77%-4M | 2,710.53%496M | -175.00%-22M | --0 | 50.00%-2M | 17,433.33%520M | 48.65%-19M | 73.33%-8M |
| -Less:Restructuring and mergern&acquisition | --3M | -50.00%1M | --4M | -71.43%4M | -33.33%2M | --0 | -50.00%2M | --0 | -62.16%14M | -80.00%3M |
| -Less:Other special charges | ---- | ---- | ---- | --16M | ---- | ---- | ---- | ---- | ---- | ---- |
| -Gain on sale of business | --0 | --0 | --0 | 10,500.00%520M | --0 | --0 | --0 | --520M | ---5M | ---5M |
| -Gain on sale of property,plant,equipment | ---- | ---- | ---- | ---4M | ---- | ---- | ---- | ---- | ---- | ---- |
| Other non-operating income (expenses) | ---53M | 200.00%1M | 107.14%1M | ---- | ---- | ---- | -112.50%-1M | -275.00%-14M | ---- | ---- |
| Income before tax | -96.88%2M | -2.33%42M | -91.07%50M | 177.43%713M | -41.03%46M | 3.23%64M | -2.27%43M | 667.12%560M | 1.98%257M | 41.82%78M |
| Income tax | 103.33%1M | 0.00%11M | -91.30%12M | 111.29%131M | -36.84%12M | -300.00%-30M | 10.00%11M | 666.67%138M | -8.82%62M | -17.39%19M |
| Earnings from equity interest net of tax | ||||||||||
| Net income | -98.94%1M | -3.13%31M | -91.00%38M | 198.46%582M | -42.37%34M | 100.00%94M | -5.88%32M | 667.27%422M | 5.98%195M | 84.38%59M |
| Net income continuous operations | -98.94%1M | -3.13%31M | -91.00%38M | 198.46%582M | -42.37%34M | 100.00%94M | -5.88%32M | 667.27%422M | 5.98%195M | 84.38%59M |
| Noncontrolling interests | ||||||||||
| Net income attributable to the company | -98.94%1M | -3.13%31M | -91.00%38M | 198.46%582M | -42.37%34M | 100.00%94M | -5.88%32M | 667.27%422M | 5.98%195M | 84.38%59M |
| Preferred stock dividends | ||||||||||
| Other under preferred stock dividend | ||||||||||
| Net income attributable to common stockholders | -98.94%1M | -3.13%31M | -91.00%38M | 198.46%582M | -42.37%34M | 100.00%94M | -5.88%32M | 667.27%422M | 5.98%195M | 84.38%59M |
| Diluted earnings per share | 0 | 16.67%0.14 | -89.33%0.16 | 245.45%2.28 | -10.00%0.18 | 143.75%0.39 | 9.09%0.12 | 733.33%1.5 | 11.86%0.66 | 100.00%0.2 |
| Basic earnings per share | 0 | 16.67%0.14 | -89.12%0.16 | 246.15%2.25 | -10.00%0.18 | 143.75%0.39 | 9.09%0.12 | 716.67%1.47 | 10.17%0.65 | 100.00%0.2 |
| Dividend per share | 0.00%0.1 | 0.00%0.1 | 0.00%0.1 | 0.00%0.4 | 0.00%0.1 | 0.00%0.1 | 0.00%0.1 | 0.00%0.1 | 226.53%0.4 | 0.00%0.1 |
| Accounting Standards | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP | US-GAAP |
| Audit Opinions | -- | -- | -- | Unqualified Opinion | -- | -- | -- | -- | Unqualified Opinion | -- |
FY: Financial Year. Refers to the 10-K file disclosed by the listed company to the SEC.
Q: Quarter. Refers to the 10-Q file disclosed by the listed company to the SEC. Q1, Q2, Q3, and Q4 are quarterly reports each with a span of 3 months; Q6 and Q9 are cumulative reports, with Q6 including 6 months and Q9 9 months.